MedTrace Logo

The Effect of DASH Diet on the Cardiometabolic Risks and Hepatic Function Among Type 2 Diabetic Patients

NCT01049321 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2010-01-14

No results posted yet for this study

Summary

The investigators are not aware of any study regarding the effect of DASH eating pattern on different cardiovascular risks among type 2 diabetic patients. The investigators assumed that DASH eating pattern could reduce the cardio-metabolic risks and improve the hepatic function among type 2 diabetes.

Conditions

  • Type 2 Diabetic Patients

Interventions

DIETARY_SUPPLEMENT

DASH diet

DIETARY_SUPPLEMENT

a usual diabetic diet

Sponsors & Collaborators

  • Shahid Motahari Hospital of Fooladshahr, Isfahan Steel Company, Isfahan

    collaborator UNKNOWN

  • Isfahan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Leila Azadbakht, PhD · Isfahan University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
44 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2009-06-30
Completion
2009-12-31

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01049321 on ClinicalTrials.gov